Microbot Medical MBOT Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -27.6%+4.8pp | -32.4%-0.6pp | -31.9%+37.9pp | -69.8%-3.3pp | -66.5%+218pp | |
| Return on invested capital | -33%+6.3pp | -39.3%-2.2pp | -37.1%+52.6pp | -89.6%-10.8pp | -78.9%+754pp | |
| Liquidity | ||||||
| Current ratio | 22.6×-0.7× | 23.3×-4.2× | 27.5×+15.5× | 12.1×-4.1× | 16.2×+13.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $1.10-34.9% | $1.69+4.1% | $1.63+95.5% | $0.83-10.7% | $0.93+313% | |
| Valuation | ||||||
| Market capitalization | $128.28M+36.1% | $134.32M-16.6% | $161.02M+72.9% | $93.13M+77.5% | $52.46M+177% | |
| Price / book | 1.7×-1.4× | 1.7×-0.3× | 2.1×-1.0× | 3.1×+1.3× | 1.8×-3.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Microbot Medical's ratios come from?
- Every ratio is computed from Microbot Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
